MTOR and renal cell carcinoma: The somatically mutated genes discovered in this study were used to evaluate the impact on the major signaling pathways associated with RCC, including the PI3K-Akt, mTOR, p53, HIF-1, Hippo, MAPK signaling pathways and the SWI/SNF complex [3, 4, 14].